hotspot -WSS

hotspot

author：Wikipedia 2025-10-01 23:43:29 - browse：95

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： 'Brian's Song' at 50 still offers lessons about cancer for today

entertainment

WSS

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

Judge in Trump's classified documents case questions use of out

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

NFL doctors' conflicts of interest could endanger players, report says

knowledge

hotspot

entertainment

New air purifier tech could be key to improving indoor air quality

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Tori Bowie and the unacceptable rates of Black maternal death

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Europe is fastest

Apple is now the first public company to be valued at $3 trillion

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Cancer drug shortages should be causing more outrage

Feed a cold, starve a fever? Here’s what science says

Wikipedia

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Flash flood warnings continue for parts of Missouri, Illinois

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

entertainment

focus

hotspot

explore